Kingdon Capital Management, L.L.C. Eli Lilly & CO Put Options Transaction History

Kingdon Capital Management, L.L.C.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $15.5 Million - $18.2 Million	50,000 New	50,000 $17.2 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $31.8 Million - $35.6 Million	-300,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $25.8 Million - $32.2 Million	300,000 New	300,000 $32.2 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.